Literature DB >> 15411745

Preliminary report on the clinical use of a new anticoagulant, phenylindandione.

A U BLAUSTEIN, J J CROCE, M ALBERIAN, N RICHEY.   

Abstract

Entities:  

Keywords:  PHENYLINDANEDIONE; THROMBOSIS

Mesh：

Substances：

Year:  1950        PMID： 15411745     DOI： 10.1161/01.cir.1.5.1195

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  7 in total

1.  Clinical evaluation of miradon.

Authors:  G KELLAWAY
Journal:  Br Med J       Date:  1958-10-11

2.  An evaluation of long-term anticoagulant therapy.

Authors:  M M SUZMAN
Journal:  Postgrad Med J       Date:  1956-04       Impact factor: 2.401

3.  Vitamin K1 in the control of phenylindanedione-induced anticoagulant therapy.

Authors:  A ENGLISH; S R TOWNSEND; D G CAMERON
Journal:  Can Med Assoc J       Date:  1955-02-01       Impact factor: 8.262

4.  Phenylindanedione: a useful anticoagulant.

Authors:  S R TOWNSEND; K J FAY; J R DOWNING; R LAING; D G CAMERON
Journal:  Can Med Assoc J       Date:  1953-08       Impact factor: 8.262

5.  Clinical trial of phenylindanedione as an anticoagulant.

Authors:  M TOOHEY
Journal:  Br Med J       Date:  1953-03-21

6.  Therapeutic evaluation of a new anticoagulant, phenylindandione.

Authors:  W W COON; I F DUFF; P E HODGSON; E W DENNIS
Journal:  Ann Surg       Date:  1953-09       Impact factor: 12.969

7.  [The effect of phenylindanedione on the coagulation factors prothrombin, factor V and factor VII and the question of vitamin K resistance].

Authors:  E PERLICK
Journal:  Klin Wochenschr       Date:  1953-03-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.